SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India inks MoU with NIPER Kolkata

17 Nov 2016 Evaluate

Sanofi India (SIL) has signed a Memorandum of Understanding (MoU) with NIPER Kolkata, an autonomous body set up under the aegis of Department of Pharmaceuticals, Government of India, to promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the Pharmaceutical industry.

Through this initiative, Sanofi India will participate in revision or formulation of curriculum for a Post-Graduate (M.S.)/Ph.D. rogramme; provide opportunities of internship or project work to NIPER Kolkata M.S./Ph.D. students at manufacturing sites; ensure association of R&D heads with the dissertation work of NIPER Students; provide career growth opportunities; and undertake collaborative research activities in identified areas.

As per the MoU, the key deliverables for Sanofi India will be to assist NIPER Kolkata foster students with updated knowledge, and who are ready for the pharmaceutical industry.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.

Sanofi India Share Price

3559.80 -0.20 (-0.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×